The 2024 RNDS


The 2024 Rare Neuroimmune Disorders Symposium (RNDS) will take place October 18-20th in Dallas, TX. The RNDS is a 3-day educational event for those with ADEM, AFM, MOGAD, NMOSD, ON, and TM, as well as their families, care partners, and medical professionals. Patients will be able to learn about their diagnosis, symptom management, rehabilitation, the latest research, and more. This event is also a great opportunity for patients and their families to meet others who are diagnosed with a rare neuroimmune disorder and find community with those who share similar journeys.

Do you have patients who may be interested in attending the 2024 RNDS? Download the flyer for your clinic here.

This will be a hybrid event, where participants can choose to attend either in-person, virtually via online streaming, or partly in-person and partly online. More information about the venue, booking a hotel room, tickets, and the agenda are on the RNDS event page.

We encourage you to share about the RNDS with your rare neuroimmune patients. Also, while the presentations are geared toward patients, we welcome medical professionals to attend, as this event offers the chance to network and collaborate with other neuroimmune specialists.

If you have any questions about the 2024 RNDS, please feel free to email Krissy Dilger at [email protected].



Other articles in this issue

The 2024 Rare Neuroimmune Disorders Symposium (RNDS) will be held October 18-20th in Dallas, TX. Share the event with your patients!

SRNA has recognized four new Centers of Excellence in Rare Neuroimmune Disorders (CERNDs)! Learn about the benefits of becoming a CERND.

SRNA partnered with Dr. Benjamin Greenberg to create a micro-learning course in the field of rare neuroimmune disorders for patients.

SRNA offers a variety of programs to support those diagnosed with a rare neuroimmune disorder. Share about our education and support programs with your patients.

SRNA invites you to become a guest on Community Meets Clinic, a podcast series that introduces healthcare professionals and their centers to the rare neuroimmune community.